Sign in Subscribe

Latest

23
Sep

Foundayo: Orforglipron — The Next Generation of Oral Metabolic Medicine

Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 23, 2026 Medical Note This article is
40 min read
23
Sep

Orforglipron Explained: The First True Non-Peptide Oral GLP-1

Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 23, 2026 Medical Note This article is
13 min read
22
Sep

The Wegovy Pill: How Once-Daily Oral Semaglutide Compares to Injections

Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 22, 2026 Medical Note This article is
15 min read
22
Sep

Rybelsus: Oral Semaglutide

Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 22, 2026 Medical Note This article is
24 min read
21
Sep

Oral vs. Injectable GLP-1s: How Daily Pills Compare to Weekly Injections

Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 21, 2026 Medical Note This article is
11 min read
21
Sep

Trulicity: Weekly Dulaglutide

Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 21, 2026 Medical Note This article is
27 min read
20
Sep

Victoza: Daily Liraglutide for Type 2 Diabetes

Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 20, 2026 Medical Note This article is
12 min read
20
Sep

Saxenda: Daily Liraglutide for Weight Management

Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 20, 2026 Medical Note This article is
14 min read
19
Sep

Older GLP-1 Agonists: Saxenda, Victoza, and Trulicity in the Modern Era

Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 19, 2026 Medical Note This article is
13 min read
19
Sep

Retatrutide and the Future of Triple Agonists (GLP-1, GIP, Glucagon)

Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 19, 2026 Medical Note This article is
11 min read